At the same time, the company will work on reaching originally stated efficiency and cost targets. This means that Cronos' cultured cannabinoid products will be the first to market in Canada, providing the company with important feedback in terms of consumers' opinions, which will help it further develop new products. The company projects it will reach its final productivity target for CBG before September, which was announced earlier. The agreement change comes on the heels of Cronos Fermentation obtaining a processing and a CRA license.